Differences in tumor characteristics could explain sex- and race-based disparities in patients with metastatic non-small cell lung cancer.
All articles by Alan P. Lyss, MD
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
The 2-year overall survival rate was 32.5%.
A meta-analysis revealed inferior responses, progression-free survival, and overall survival in patients exposed to antibiotics.
Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Latest News Your top articles for SundayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses